Search Details

Word: generic (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...During the debate, some generic companies went to Capitol Hill with a concern: BMS was asking the FDA to approve a new interpretation of the agency's rules that, if successful, would allow it to use the findings from its pediatric study - for which it already received six months of additional monopoly - to keep generic versions of the drug off the market for an extra 3 years. The reason? FDA regs entitle companies that change their labels due to new research to have an extra three years of exclusivity. BMS argued that since data gleaned from its pediatric study...

Author: /time Magazine | Title: Bristol-Myers Squibb Lobbies for a Patent Loophole | 11/2/2001 | See Source »

...including products like Pfizer's anti-seizure medication Neurotonin, with revenues of $2.5 billion per year, most realized a fix was needed, and other brand-name drugmakers didn't like the notion of an exemption for BMS. The Senate approved a bill with a provision clarifying that generic drugmakers can sell their version of a drug in an adult form even if the brand- name maker has changed its label by adding new pediatric information. The House bill that passed in committee has similar language; a vote on the House floor could happen Tuesday. But generic drugmakers and other opponents...

Author: /time Magazine | Title: Bristol-Myers Squibb Lobbies for a Patent Loophole | 11/2/2001 | See Source »

...PATENT Bayer holds the patent on Cipro until 2003. Despite congressional pressure and news that Canadian health authorities have decided to break Bayer's patent, HHS decided against permitting other companies to make generic versions of Cipro. It maintained that Cipro (Bayer is tripling production) as well as other antibiotics, would be sufficient to meet any bump in demand...

Author: /time Magazine | Title: Anthrax: A Medical Guide | 10/29/2001 | See Source »

...under different names across Europe. U.S. Secretary of Health and Human Services Tommy Thompson said negotiations were underway with Bayer to relax its patent on Cipro; the company wouldn?t comment. No wonder: a month?s supply of Cipro retails for a steep $350 in the U.S., while the generic version in India costs about $10. The Cipro patent has expired in Germany but will run until December...

Author: /time Magazine | Title: Bayer's Silver Bullet | 10/29/2001 | See Source »

...approach to maintaining American preparedness was indicated by yesterday’s agreement between Bayer and the Canadian government. Last week, citing “extraordinary and unusual times,” the Canadian government announced it would ignore the Bayer patent and authorized the production of 1 million generic tablets by a Canadian company. After high-intensity negotiations, Canada yesterday reversed its position as Bayer agreed to supply the tablets within 48 hours—before the generic tablets would have been ready—at a discounted price...

Author: By The CRIMSON Staff, CRIMSON STAFF WRITER | Title: Paying the Price for Cipro | 10/24/2001 | See Source »

Previous | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | Next